BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18412534)

  • 1. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
    Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
    J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
    J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
    Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
    J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen.
    Fan TM; Kitchell BE; Dhaliwal RS; Jones PD; Hintermeister JG; Paria BC
    J Am Anim Hosp Assoc; 2002; 38(4):357-63. PubMed ID: 12118689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
    Dutelle AL; Bulman-Fleming JC; Lewis CA; Rosenberg MP
    J Feline Med Surg; 2012 Oct; 14(10):694-700. PubMed ID: 22577051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell tumors in cats: clinical update and possible new treatment avenues.
    Henry C; Herrera C
    J Feline Med Surg; 2013 Jan; 15(1):41-7. PubMed ID: 23254240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of treatment for mast cell tumors.
    Govier SM
    Clin Tech Small Anim Pract; 2003 May; 18(2):103-6. PubMed ID: 12831070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia.
    Litster AL; Sorenmo KU
    J Feline Med Surg; 2006 Jun; 8(3):177-83. PubMed ID: 16476559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat.
    Komori S; Nakamura S; Takahashi K; Tagawa M
    J Am Vet Med Assoc; 2005 Jan; 226(2):237-9, 219. PubMed ID: 15706974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
    Hosoya K; Kisseberth WC; Alvarez FJ; Lara-Garcia A; Beamer G; Stromberg PC; Couto CG
    J Am Anim Hosp Assoc; 2009; 45(1):14-8. PubMed ID: 19122059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous mast cell neoplasia in cats: 14 cases (1975-1985).
    Buerger RG; Scott DW
    J Am Vet Med Assoc; 1987 Jun; 190(11):1440-4. PubMed ID: 3112049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of canine mast cell tumors with CCNU (lomustine).
    Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM
    J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992-2002).
    Turrel JM; Farrelly J; Page RL; McEntee MC
    J Am Vet Med Assoc; 2006 Mar; 228(6):898-901. PubMed ID: 16536702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
    Rau SE; Burgess KE
    Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
    Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
    J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.